IN
Indiana Senate Bill SB0209

Indiana 2022 Regular Session

Indiana Senate Bill SB0209 Compare Versions

OldNewDifferences
1-*ES0209.1*
2-February 17, 2022
3-ENGROSSED
1+*SB0209.2*
2+Reprinted
3+January 25, 2022
44 SENATE BILL No. 209
55 _____
6-DIGEST OF SB 209 (Updated February 16, 2022 2:50 pm - DI 131)
7-Citations Affected: IC 35-31.5; IC 35-48; noncode.
6+DIGEST OF SB 209 (Updated January 24, 2022 3:48 pm - DI 106)
7+Citations Affected: IC 15-15; IC 24-4; IC 35-31.5; IC 35-48.
88 Synopsis: Drug schedules. Adds specified substances to the scheduled
9-list of controlled substances. Urges the legislative council to assign to
10-the interim study committee on corrections and criminal code, during
11-the 2022 legislative interim, the task of studying "delta-8 THC" and any
12-of its related psychoactive cannabinoids.
13-Effective: Upon passage; July 1, 2022.
14-Young M, Brown L
15-(HOUSE SPONSORS — STEUERWALD, YOUNG J)
9+list of controlled substances. Replaces references to "delta-9 THC" with
10+"THC".
11+Effective: July 1, 2022.
12+Young M
1613 January 6, 2022, read first time and referred to Committee on Corrections and Criminal
1714 Law.
1815 January 20, 2022, amended, reported favorably — Do Pass.
1916 January 24, 2022, read second time, amended, ordered engrossed.
20-January 25, 2022, engrossed. Returned to second reading.
21-January 27, 2022, re-read second time, amended, ordered engrossed.
22-January 28, 2022, re-engrossed.
23-February 1, 2022, read third time, passed. Yeas 36, nays 12.
24-HOUSE ACTION
25-February 7, 2022, read first time and referred to Committee on Courts and Criminal Code.
26-February 17, 2022, amended, reported — Do Pass.
27-ES 209—LS 6921/DI 92 February 17, 2022
17+SB 209—LS 6921/DI 92 Reprinted
18+January 25, 2022
2819 Second Regular Session of the 122nd General Assembly (2022)
2920 PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
3021 Constitution) is being amended, the text of the existing provision will appear in this style type,
3122 additions will appear in this style type, and deletions will appear in this style type.
3223 Additions: Whenever a new statutory provision is being enacted (or a new constitutional
3324 provision adopted), the text of the new provision will appear in this style type. Also, the
3425 word NEW will appear in that style type in the introductory clause of each SECTION that adds
3526 a new provision to the Indiana Code or the Indiana Constitution.
3627 Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
3728 between statutes enacted by the 2021 Regular Session of the General Assembly.
38-ENGROSSED
3929 SENATE BILL No. 209
4030 A BILL FOR AN ACT to amend the Indiana Code concerning
4131 criminal law and procedure.
4232 Be it enacted by the General Assembly of the State of Indiana:
43-1 SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
44-2 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
45-3 JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
46-4 (1) a substance containing one (1) or more of the following
47-5 chemical compounds, including an analog of the compound and
48-6 its isomers, salts, and salts of isomers:
49-7 (A) JWH-015 ((2-Methyl-1-propyl-1H-
50-8 indol-3-yl)-1-naphthalenylmethanone).
51-9 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
52-10 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
53-11 (D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
54-12 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
55-13 3-yl)methanone).
56-14 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
57-15 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
58-16 naphthalen-1-yl-methanone).
59-17 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
60-ES 209—LS 6921/DI 92 2
61-1 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
62-2 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
63-3 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
64-4 3-(2-methyloctan-2-yl)-
65-5 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
66-6 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
67-7 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
68-8 [c]chromen-1-ol).
69-9 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
70-10 (2-methyloctan- 2-yl)phenyl]-
71-11 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
72-12 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
73-13 (1-methylethenyl)-2 -cyclohexen-1-yl]-5
74-14 -pentyl-2,5-cyclohexadiene-1,4-dione).
75-15 (O) CP 55,940
76-16 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
77-17 5- (2-methyloctan-2-yl)phenol).
78-18 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
79-19 (2-methyloctan-2-yl)phenol) and its homologues, or
80-20 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
81-21 phenol), where side chain n=5, and homologues where side
82-22 chain n=4, 6, or 7.
83-23 (Q) WIN 55212-2
84-24 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
85-25 pyrrolo [1,2,3-de)- 1,4- benzoxazin-
86-26 6-yl]-1-napthalenylmethanone).
87-27 (R) RCS-4 ((4-methoxyphenyl)
88-28 (1-pentyl-1H-indol-3-yl)methanone).
89-29 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
90-30 indol-3-yl)-2-(2-methoxyphenyl)ethanone).
91-31 (T) 4-Methylmethcathinone. Other name: mephedrone.
92-32 (U) 3,4-Methylenedioxymethcathinone. Other name:
93-33 methylone.
94-34 (V) Fluoromethcathinone.
95-35 (W) 4-Methoxymethcathinone. Other name: methedrone.
96-36 (X) 4-Ethylmethcathinone (4-EMC).
97-37 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
98-38 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
99-39 (AA) JWH-098, or
100-40 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
101-41 (BB) JWH-164, or
102-42 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
103-ES 209—LS 6921/DI 92 3
104-1 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
105-2 (DD) JWH-201, or
106-3 1-pentyl-3-(4-methoxyphenylacetyl)indole.
107-4 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
108-5 (FF) AM-694, or
109-6 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
110-7 (GG) CP 50,556-1, or
111-8 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
112-9 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
113-10 -yl] acetate.
114-11 (HH) Dimethylheptylpyran, or DMHP.
115-12 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
116-13 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
117-14 (LL) 7-hydroxymitragynine.
118-15 (MM) á-PPP [á-pyrrolidinopropiophenone].
119-16 (NN) á-PVP (desmethylpyrovalerone).
120-17 (OO) AM-251.
121-18 (PP) AM-1241.
122-19 (QQ) AM-2201.
123-20 (RR) AM-2233.
124-21 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
125-22 (TT) Butylone.
126-23 (UU) CP-47,497-C7.
127-24 (VV) CP-47,497-C8.
128-25 (WW) Desoxypipradol.
129-26 (XX) Ethylone.
130-27 (YY) Eutylone.
131-28 (ZZ) Flephedrone.
132-29 (AAA) JWH-011.
133-30 (BBB) JWH-020.
134-31 (CCC) JWH-022.
135-32 (DDD) JWH-030.
136-33 (EEE) JWH-182.
137-34 (FFF) JWH-302.
138-35 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
139-36 (HHH) Mitragynine.
140-37 (III) Naphyrone.
141-38 (JJJ) Pentedrone.
142-39 (LLL) Pentylone.
143-40 (MMM) Methoxetamine
144-41 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
145-42 (NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
146-ES 209—LS 6921/DI 92 4
147-1 (2,2,3,3-tetramethylcyclopropyl)methanone].
148-2 (OOO) AB-001[(1s,3s)-admantan-1-yl)
149-3 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
150-4 (1-adamantoyl)indole].
151-5 (PPP) AM-356 [Methanandamide].
152-6 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
153-7 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
154-8 [(1-[(N-methylpiperindin-2-yl)
155-9 Methyl]-3-(Adamant-1-oyl)indole)].
156-10 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)
157-11 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
158-12 (SSS) CB-13 [1-Naphthalenyl
159-13 [4-(pentyoxy)- 1-naphthalenyl]methanone].
160-14 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
161-15 (2,2,3,3-tetramethylcyclopropyl)-methanone].
162-16 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
163-17 cyclohexylcarbamate].
164-18 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
165-19 cyclohexyl ester].
166-20 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
167-21 amino]-1-benzoxazin-4-one].
168-22 (XXX) XLR-11 or 5-fluoro UR-144
169-23 (1-(5-fluoropentyl)-1H-indol-3-yl)
170-24 (2,2,3,3-tetramethylcyclopropyl)methanone].
171-25 (YYY) AKB48 (Other names include:
172-26 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
173-27 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
174-28 carboxamide).
175-29 (ZZZ) 25I-NBOMe (Other names include:
176-30 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
177-31 benzeneethanamine);
178-32 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
179-33 methyl]ethanamine).
180-34 (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
181-35 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
182-36 methyl]ethanamine;
183-37 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
184-38 phenethylamine).
185-39 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
186-40 (1-adamantylamido)indole).
187-41 (CCCC) STS-135 (Other names include:
188-42 N-Adamantyl-1-fluoropentylindole-3- carboxamide
189-ES 209—LS 6921/DI 92 5
190-1 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
191-2 indole-3-carboxamide).
192-3 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
193-4 ester-1H-indole-2-carboxylic acid).
194-5 (EEEE) 5-Fluoro-PB-22 (Other names include:
195-6 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
196-7 acid).
197-8 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and
198-9 Benzothiophenylcyclohexylpiperidine).
199-10 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
200-11 and 4-Bromo-2,
201-12 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
202-13 benzeneethanamine).
203-14 (HHHH) APB (Other names include: (2-Aminopropyl)
204-15 Benzofuran).
205-16 (IIII) AB-PINACA
206-17 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
207-18 indazole-3-carboxamide.
208-19 (JJJJ) AB-FUBINACA
209-20 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
210-21 1H-indazole-3-carboxamide).
211-22 (KKKK) ADB-PINACA
212-23 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
213-24 indaole-3-carboxamide).
214-25 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
215-26 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
216-27 carboxamide).
217-28 (MMMM) APDB (Other names include: -EMA,
218-29 -Desoxy-MDA, and (2-Aminopropyl)-2,3-
219-30 dihydrobenzofuran).
220-31 (NNNN) THJ-2201 (Other names include: AM2201 indazole
221-32 analog, Fluoropentyl-JWH-018 indazole, and
222-33 5-Fluoro-THJ-018).
223-34 (OOOO) AM 2201 benzimidazole analog (Other names
224-35 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
225-36 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
226-37 (PPPP) MN-25 (Other names include: 7-methoxy-1-
227-38 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
228-39 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
229-40 and UR-12).
230-41 (QQQQ) FUB-PB-22 (Other names include:
231-42 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
232-ES 209—LS 6921/DI 92 6
233-1 (RRRR) FUD-PB-22 (Other names include:
234-2 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
235-3 (SSSS) 5-Fluoro-AB-PINACA (Other names include:
236-4 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
237-5 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
238-6 carboxaminde).
239-7 (TTTT) 4-MePPP (Other names include:
240-8 4-methyl-alpha-pyrrolidinopropiophenone).
241-9 (UUUU) alpha-PBP (Other names include:
242-10 Alpha-pyrrolidinobutiophenone).
243-11 (VVVV) AB-CHMINACA (Other names include:
244-12 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
245-13 l)-1H-indazole-3-carboxamide).
246-14 (WWWW) Mexedrone
247-15 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
248-16 (XXXX) MT-45,
249-17 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
250-18 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
251-19 carboxamido) -3,3-dimethylbutanoate [5F-ADB;
252-20 5F-MDMB-PINACA].
253-21 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
254-22 carboxamido)-3-methylbutanoate [5F-AMB].
255-23 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
256-24 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
257-25 [ADB-FUBINACA].
258-26 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
259-27 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
260-28 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
261-29 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
262-30 MMB-CHMINACA].
263-31 (DDDDD) methyl 2-(1-(4-fluorobenzyl)-
264-32 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
265-33 [MDMB-FUBINACA].
266-34 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
267-35 (cyclohexylmethyl)- 1H-indazole-3-carboxamide
268-36 [MAB-CHMINACA and ADB-CHMINACA].
269-37 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
270-38 3-carboxamido)- 3-methylbutanoate [FUB-AMB,
271-39 MMB-FUBINACA, AMB-FUBINACA].
272-40 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
273-41 thyl]benzamide) [AH7921].
274-42 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
275-ES 209—LS 6921/DI 92 7
276-1 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
277-2 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
278-3 H-indazole-3-carboxamide (trivial name:
279-4 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
280-5 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
281-6 (JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
282-7 H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
283-8 MMB-CHMICA, AMB-CHMICA).
284-9 (KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
285-10 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
286-11 5F-CUMYL-P7AICA).
287-12 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
288-13 entanone (N-ethylpentylone, ephylone).
289-14 (MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
290-15 (ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
291-16 its optical, positional, and geometric isomers, salts, and salts
292-17 of isomers.
293-18 (NNNNN) ethyl
294-19 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
295-20 dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
296-21 (OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
297-22 carboxamido)-3,3-dimethylbutanoate (trivial name:
298-23 5F-MDMB-PICA).
299-24 (PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
300-25 1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
301-26 FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
302-27 (QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
303-28 1H-indazole-3-carboxamide (trivial names:
304-29 5F-CUMYL-PINACA; SGT-25).
305-30 (RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
306-31 yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
307-32 FUB-144).
308-33 (SSSSS) 4F-MDMB-BINACA.
309-34 (TTTTT) N-ethylhexedrone
310-35 (2-(ethylamino)-1-phenylhexan-1-one).
311-36 (UUUUU) alpha-pyrrolidinohexanophenone
312-37 (1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
313-38 (VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
314-39 a-PHP.
315-40 (WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
316-41 (1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
317-42 (XXXXX) 4-methyl-alphaethylaminopentiophenone
318-ES 209—LS 6921/DI 92 8
319-1 (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
320-2 name: 4–MEAP.
321-3 (YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
322-4 name: MPHP.
323-5 (ZZZZZ) alphapyrrolidinoheptaphenone
324-6 (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
325-7 (AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
326-8 chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
327-9 (BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
328-10 name: 4-chloro-a-PVP.
329-11 (CCCCCC) 4,4'-dimethylaminorex (common name:
330-12 4,4'-DMAR).
331-13 (2) Any compound structurally derived from
332-14 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
333-15 substitution at the nitrogen atom of the indole ring by alkyl,
334-16 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
335-17 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
336-18 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
337-19 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
338-20 or not further substituted in the indole ring to any extent and
339-21 whether or not substituted in the naphthyl ring to any extent.
340-22 (3) Any compound structurally derived from 3-(1-naphthoyl)
341-23 pyrrole by substitution at the nitrogen atom of the pyrrole ring by
342-24 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
343-25 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
344-26 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
345-27 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
346-28 group, whether or not further substituted in the pyrrole ring to any
347-29 extent and whether or not substituted in the naphthyl ring to any
348-30 extent.
349-31 (4) Any compound structurally derived from
350-32 1-(1-naphthylmethyl)indene by substitution at the 3-position of
351-33 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
352-34 cycloalkylmethyl, cycloalkylethyl,
353-35 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
354-36 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
355-37 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
356-38 or not further substituted in the indene ring to any extent and
357-39 whether or not substituted in the naphthyl ring to any extent.
358-40 (5) Any compound structurally derived from 3-phenylacetylindole
359-41 by substitution at the nitrogen atom of the indole ring with alkyl,
360-42 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
361-ES 209—LS 6921/DI 92 9
362-1 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
363-2 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
364-3 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
365-4 or not further substituted in the indole ring to any extent and
366-5 whether or not substituted in the phenyl ring to any extent.
367-6 (6) Any compound structurally derived from
368-7 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
369-8 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
370-9 cycloalkylmethyl, cycloalkylethyl,
371-10 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
372-11 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
373-12 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
374-13 or not substituted in the cyclohexyl ring to any extent.
375-14 (7) Any compound containing a 3-(benzoyl)indole structure with
376-15 substitution at the nitrogen atom of the indole ring by alkyl,
33+1 SECTION 1. IC 15-15-13-6.5, AS ADDED BY P.L.190-2019,
34+2 SECTION 7, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
35+3 JULY 1, 2022]: Sec. 6.5. As used in this chapter, "hemp product"
36+4 means a product derived from, or made by, processing hemp plants or
37+5 plant parts including derivatives, extracts, cannabinoids, isomers, acids,
38+6 salts, and salts of isomers. However, the term does not include:
39+7 (1) smokable hemp (as defined by IC 35-48-1-26.6); or
40+8 (2) products that contain a total delta-9-tetrahydrocannabinol
41+9 tetrahydrocannabinol concentration of more than three-tenths
42+10 of one percent (0.3%) by weight.
43+11 SECTION 2. IC 24-4-21-3, AS AMENDED BY P.L.190-2019,
44+12 SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
45+13 JULY 1, 2022]: Sec. 3. A person may distribute low THC hemp extract
46+14 in Indiana only if the distributor has a certificate of analysis prepared
47+15 by an independent testing laboratory showing:
48+16 (1) that the low THC hemp extract is the product of a batch tested
49+17 by the independent testing laboratory;
50+SB 209—LS 6921/DI 92 2
51+1 (2) that the independent testing laboratory determined that the
52+2 batch contained not more than three-tenths percent (0.3%) total
53+3 delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
54+4 including precursors and isomers, by weight, based on the testing
55+5 of a random sample of the batch; and
56+6 (3) the cannabidiol percent present of the low THC hemp extract.
57+7 SECTION 3. IC 24-4-21-4, AS ADDED BY P.L.153-2018,
58+8 SECTION 9, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
59+9 JULY 1, 2022]: Sec. 4. (a) Except as provided in subsection (b), low
60+10 THC hemp extract must be distributed in packaging that contains the
61+11 following information:
62+12 (1) A scannable bar code or QR code linked to a document that
63+13 contains information with respect to the manufacture of the low
64+14 THC hemp extract, including the:
65+15 (A) batch identification number;
66+16 (B) product name;
67+17 (C) batch date;
68+18 (D) expiration date, which must be not more than two (2) years
69+19 from the date of manufacture;
70+20 (E) batch size;
71+21 (F) total quantity produced;
72+22 (G) ingredients used, including the:
73+23 (i) ingredient name;
74+24 (ii) name of the company that manufactured the ingredient;
75+25 (iii) company or product identification number or code, if
76+26 applicable; and
77+27 (iv) ingredient lot number; and
78+28 (H) download link for a certificate of analysis for the low THC
79+29 hemp extract.
80+30 (2) The batch number.
81+31 (3) The Internet address of a web site to obtain batch information.
82+32 (4) The expiration date.
83+33 (5) The number of milligrams of low THC hemp extract.
84+34 (6) The manufacturer.
85+35 (7) The fact that the product contains not more than three-tenths
86+36 percent (0.3%) total delta-9-tetrahydrocannabinol
87+37 tetrahydrocannabinol (THC), including precursors and isomers,
88+38 by weight.
89+39 (b) Before July 1, 2018, low THC hemp extract may be distributed
90+40 in Indiana without having met the requirements described in subsection
91+41 (a).
92+42 SECTION 4. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
93+SB 209—LS 6921/DI 92 3
94+1 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
95+2 JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
96+3 (1) a substance containing one (1) or more of the following
97+4 chemical compounds, including an analog of the compound and
98+5 its isomers, salts, and salts of isomers:
99+6 (A) JWH-015 ((2-Methyl-1-propyl-1H-
100+7 indol-3-yl)-1-naphthalenylmethanone).
101+8 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
102+9 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
103+10 (D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
104+11 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
105+12 3-yl)methanone).
106+13 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
107+14 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
108+15 naphthalen-1-yl-methanone).
109+16 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
110+17 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
111+18 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
112+19 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
113+20 3-(2-methyloctan-2-yl)-
114+21 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
115+22 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
116+23 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
117+24 [c]chromen-1-ol).
118+25 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
119+26 (2-methyloctan- 2-yl)phenyl]-
120+27 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
121+28 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
122+29 (1-methylethenyl)-2 -cyclohexen-1-yl]-5
123+30 -pentyl-2,5-cyclohexadiene-1,4-dione).
124+31 (O) CP 55,940
125+32 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
126+33 5- (2-methyloctan-2-yl)phenol).
127+34 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
128+35 (2-methyloctan-2-yl)phenol) and its homologues, or
129+36 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
130+37 phenol), where side chain n=5, and homologues where side
131+38 chain n=4, 6, or 7.
132+39 (Q) WIN 55212-2
133+40 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
134+41 pyrrolo [1,2,3-de)- 1,4- benzoxazin-
135+42 6-yl]-1-napthalenylmethanone).
136+SB 209—LS 6921/DI 92 4
137+1 (R) RCS-4 ((4-methoxyphenyl)
138+2 (1-pentyl-1H-indol-3-yl)methanone).
139+3 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
140+4 indol-3-yl)-2-(2-methoxyphenyl)ethanone).
141+5 (T) 4-Methylmethcathinone. Other name: mephedrone.
142+6 (U) 3,4-Methylenedioxymethcathinone. Other name:
143+7 methylone.
144+8 (V) Fluoromethcathinone.
145+9 (W) 4-Methoxymethcathinone. Other name: methedrone.
146+10 (X) 4-Ethylmethcathinone (4-EMC).
147+11 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
148+12 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
149+13 (AA) JWH-098, or
150+14 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
151+15 (BB) JWH-164, or
152+16 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
153+17 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
154+18 (DD) JWH-201, or
155+19 1-pentyl-3-(4-methoxyphenylacetyl)indole.
156+20 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
157+21 (FF) AM-694, or
158+22 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
159+23 (GG) CP 50,556-1, or
160+24 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
161+25 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
162+26 -yl] acetate.
163+27 (HH) Dimethylheptylpyran, or DMHP.
164+28 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
165+29 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
166+30 (LL) 7-hydroxymitragynine.
167+31 (MM) á-PPP [á-pyrrolidinopropiophenone].
168+32 (NN) á-PVP (desmethylpyrovalerone).
169+33 (OO) AM-251.
170+34 (PP) AM-1241.
171+35 (QQ) AM-2201.
172+36 (RR) AM-2233.
173+37 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
174+38 (TT) Butylone.
175+39 (UU) CP-47,497-C7.
176+40 (VV) CP-47,497-C8.
177+41 (WW) Desoxypipradol.
178+42 (XX) Ethylone.
179+SB 209—LS 6921/DI 92 5
180+1 (YY) Eutylone.
181+2 (ZZ) Flephedrone.
182+3 (AAA) JWH-011.
183+4 (BBB) JWH-020.
184+5 (CCC) JWH-022.
185+6 (DDD) JWH-030.
186+7 (EEE) JWH-182.
187+8 (FFF) JWH-302.
188+9 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
189+10 (HHH) Mitragynine.
190+11 (III) Naphyrone.
191+12 (JJJ) Pentedrone.
192+13 (LLL) Pentylone.
193+14 (MMM) Methoxetamine
194+15 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
195+16 (NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
196+17 (2,2,3,3-tetramethylcyclopropyl)methanone].
197+18 (OOO) AB-001[(1s,3s)-admantan-1-yl)
198+19 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
199+20 (1-adamantoyl)indole].
200+21 (PPP) AM-356 [Methanandamide].
201+22 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
202+23 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
203+24 [(1-[(N-methylpiperindin-2-yl)
204+25 Methyl]-3-(Adamant-1-oyl)indole)].
205+26 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)
206+27 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
207+28 (SSS) CB-13 [1-Naphthalenyl
208+29 [4-(pentyoxy)- 1-naphthalenyl]methanone].
209+30 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
210+31 (2,2,3,3-tetramethylcyclopropyl)-methanone].
211+32 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
212+33 cyclohexylcarbamate].
213+34 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
214+35 cyclohexyl ester].
215+36 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
216+37 amino]-1-benzoxazin-4-one].
217+38 (XXX) XLR-11 or 5-fluoro UR-144
218+39 (1-(5-fluoropentyl)-1H-indol-3-yl)
219+40 (2,2,3,3-tetramethylcyclopropyl)methanone].
220+41 (YYY) AKB48 (Other names include:
221+42 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
222+SB 209—LS 6921/DI 92 6
223+1 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
224+2 carboxamide).
225+3 (ZZZ) 25I-NBOMe (Other names include:
226+4 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
227+5 benzeneethanamine);
228+6 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
229+7 methyl]ethanamine).
230+8 (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
231+9 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
232+10 methyl]ethanamine;
233+11 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
234+12 phenethylamine).
235+13 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
236+14 (1-adamantylamido)indole).
237+15 (CCCC) STS-135 (Other names include:
238+16 N-Adamantyl-1-fluoropentylindole-3- carboxamide
239+17 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
240+18 indole-3-carboxamide).
241+19 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
242+20 ester-1H-indole-2-carboxylic acid).
243+21 (EEEE) 5-Fluoro-PB-22 (Other names include:
244+22 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
245+23 acid).
246+24 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and
247+25 Benzothiophenylcyclohexylpiperidine).
248+26 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
249+27 and 4-Bromo-2,
250+28 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
251+29 benzeneethanamine).
252+30 (HHHH) APB (Other names include: (2-Aminopropyl)
253+31 Benzofuran).
254+32 (IIII) AB-PINACA
255+33 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
256+34 indazole-3-carboxamide.
257+35 (JJJJ) AB-FUBINACA
258+36 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
259+37 1H-indazole-3-carboxamide).
260+38 (KKKK) ADB-PINACA
261+39 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
262+40 indaole-3-carboxamide).
263+41 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
264+42 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
265+SB 209—LS 6921/DI 92 7
266+1 carboxamide).
267+2 (MMMM) APDB (Other names include: -EMA,
268+3 -Desoxy-MDA, and (2-Aminopropyl)-2,3-
269+4 dihydrobenzofuran).
270+5 (NNNN) THJ-2201 (Other names include: AM2201 indazole
271+6 analog, Fluoropentyl-JWH-018 indazole, and
272+7 5-Fluoro-THJ-018).
273+8 (OOOO) AM 2201 benzimidazole analog (Other names
274+9 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
275+10 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
276+11 (PPPP) MN-25 (Other names include: 7-methoxy-1-
277+12 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
278+13 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
279+14 and UR-12).
280+15 (QQQQ) FUB-PB-22 (Other names include:
281+16 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
282+17 (RRRR) FUD-PB-22 (Other names include:
283+18 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
284+19 (SSSS) 5-Fluoro-AB-PINACA (Other names include:
285+20 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
286+21 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
287+22 carboxaminde).
288+23 (TTTT) 4-MePPP (Other names include:
289+24 4-methyl-alpha-pyrrolidinopropiophenone).
290+25 (UUUU) alpha-PBP (Other names include:
291+26 Alpha-pyrrolidinobutiophenone).
292+27 (VVVV) AB-CHMINACA (Other names include:
293+28 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
294+29 l)-1H-indazole-3-carboxamide).
295+30 (WWWW) Mexedrone
296+31 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
297+32 (XXXX) MT-45,
298+33 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
299+34 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
300+35 carboxamido) -3,3-dimethylbutanoate [5F-ADB;
301+36 5F-MDMB-PINACA].
302+37 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
303+38 carboxamido)-3-methylbutanoate [5F-AMB].
304+39 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
305+40 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
306+41 [ADB-FUBINACA].
307+42 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
308+SB 209—LS 6921/DI 92 8
309+1 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
310+2 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
311+3 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
312+4 MMB-CHMINACA].
313+5 (DDDDD) methyl 2-(1-(4-fluorobenzyl)-
314+6 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
315+7 [MDMB-FUBINACA].
316+8 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
317+9 (cyclohexylmethyl)- 1H-indazole-3-carboxamide
318+10 [MAB-CHMINACA and ADB-CHMINACA].
319+11 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
320+12 3-carboxamido)- 3-methylbutanoate [FUB-AMB,
321+13 MMB-FUBINACA, AMB-FUBINACA].
322+14 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
323+15 thyl]benzamide) [AH7921].
324+16 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
325+17 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
326+18 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
327+19 H-indazole-3-carboxamide (trivial name:
328+20 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
329+21 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
330+22 (JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
331+23 H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
332+24 MMB-CHMICA, AMB-CHMICA).
333+25 (KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
334+26 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
335+27 5F-CUMYL-P7AICA).
336+28 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
337+29 entanone (N-ethylpentylone, ephylone).
338+30 (MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
339+31 (ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
340+32 its optical, positional, and geometric isomers, salts, and salts
341+33 of isomers.
342+34 (NNNNN) ethyl
343+35 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
344+36 dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
345+37 (OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
346+38 carboxamido)-3,3-dimethylbutanoate (trivial name:
347+39 5F-MDMB-PICA).
348+40 (PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
349+41 1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
350+42 FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
351+SB 209—LS 6921/DI 92 9
352+1 (QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
353+2 1H-indazole-3-carboxamide (trivial names:
354+3 5F-CUMYL-PINACA; SGT-25).
355+4 (RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
356+5 yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
357+6 FUB-144).
358+7 (SSSSS) 4F-MDMB-BINACA.
359+8 (TTTTT) N-ethylhexedrone
360+9 (2-(ethylamino)-1-phenylhexan-1-one).
361+10 (UUUUU) alpha-pyrrolidinohexanophenone
362+11 (1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
363+12 (VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
364+13 a-PHP.
365+14 (WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
366+15 (1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
367+16 (XXXXX) 4-methyl-alphaethylaminopentiophenone
368+17 (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
369+18 name: 4–MEAP.
370+19 (YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
371+20 name: MPHP.
372+21 (ZZZZZ) alphapyrrolidinoheptaphenone
373+22 (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
374+23 (AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
375+24 chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
376+25 (BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
377+26 name: 4-chloro-a-PVP.
378+27 (CCCCCC) 4,4'-dimethylaminorex (common name:
379+28 4,4'-DMAR).
380+29 (2) Any compound structurally derived from
381+30 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
382+31 substitution at the nitrogen atom of the indole ring by alkyl,
383+32 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
384+33 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
385+34 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
386+35 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
387+36 or not further substituted in the indole ring to any extent and
388+37 whether or not substituted in the naphthyl ring to any extent.
389+38 (3) Any compound structurally derived from 3-(1-naphthoyl)
390+39 pyrrole by substitution at the nitrogen atom of the pyrrole ring by
391+40 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
392+41 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
393+42 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
394+SB 209—LS 6921/DI 92 10
395+1 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
396+2 group, whether or not further substituted in the pyrrole ring to any
397+3 extent and whether or not substituted in the naphthyl ring to any
398+4 extent.
399+5 (4) Any compound structurally derived from
400+6 1-(1-naphthylmethyl)indene by substitution at the 3-position of
401+7 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
402+8 cycloalkylmethyl, cycloalkylethyl,
403+9 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
404+10 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
405+11 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
406+12 or not further substituted in the indene ring to any extent and
407+13 whether or not substituted in the naphthyl ring to any extent.
408+14 (5) Any compound structurally derived from 3-phenylacetylindole
409+15 by substitution at the nitrogen atom of the indole ring with alkyl,
377410 16 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
378411 17 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
379412 18 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
380413 19 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
381414 20 or not further substituted in the indole ring to any extent and
382415 21 whether or not substituted in the phenyl ring to any extent.
383-22 (8) Any compound, except bupropion or a compound listed under
384-23 a different schedule, structurally derived from
385-24 2-aminopropan-1-one by substitution at the 1-position with either
386-25 phenyl, naphthyl, or thiophene ring systems, whether or not the
387-26 compound is further modified:
388-27 (A) by substitution in the ring system to any extent with alkyl,
389-28 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
390-29 substituents, whether or not further substituted in the ring
391-30 system by one or more other univalent substituents;
392-31 (B) by substitution at the 3-position with an acyclic alkyl
393-32 substituent;
394-33 (C) by substitution at the 2-amino nitrogen atom with alkyl,
395-34 dialkyl, benzyl, or methoxybenzyl groups; or
396-35 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
397-36 structure.
398-37 (9) Any compound structurally derived from 3-tetramethyl
399-38 cyclopropanoylindole with substitution at the nitrogen atom of the
400-39 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
401-40 cycloalkylmethyl, cycloalkylethyl,
402-41 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
403-42 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
404-ES 209—LS 6921/DI 92 10
405-1 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
406-2 or not further substituted in the indole ring to any extent and
407-3 whether or not substituted in the tetramethylcyclopropyl ring to
408-4 any extent.
409-5 (10) Any compound containing a N-(1-adamantyl)-
410-6 1H-indazole-3-carboxamide structure with substitution at the
411-7 nitrogen atom of the indazole ring by an alkyl, haloalkyl,
412-8 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
413-9 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
414-10 1-(N-methyl-2-pyrrolidinyl)methyl,
415-11 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
416-12 group, whether or not further substituted at the nitrogen atom of
417-13 the carboxamide to any extent, whether or not further substituted
418-14 in the indazole ring to any extent, and whether or not further
419-15 substituted on the adamantyl ring system to any extent. An
420-16 example of this structural class includes AKB48.
421-17 (11) Any compound containing a N-(1-adamantyl)-
422-18 1H-indole-3-carboxamide structure with substitution at the
423-19 nitrogen atom of the indole ring by an alkyl, haloalkyl,
424-20 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
425-21 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
426-22 1-(N-methyl-2-pyrrolidinyl)methyl,
427-23 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
428-24 group, whether or not further substituted at the nitrogen atom of
429-25 the carboxamide to any extent, whether or not further substituted
430-26 in the indole ring to any extent, and whether or not further
431-27 substituted on the adamantyl ring system to any extent. An
432-28 example of this structural class includes STS-135.
433-29 (12) Any compound containing a 3-(1-adamantoyl)indole
434-30 structure with substitution at the nitrogen atom of the indole ring
435-31 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
436-32 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
437-33 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
438-34 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
439-35 group, whether or not further substituted on the adamantyl ring
440-36 system to any extent. An example of this structural class includes
441-37 AM-1248.
442-38 (13) Any compound determined to be a synthetic drug by rule
443-39 adopted under IC 25-26-13-4.1.
444-40 SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
445-41 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
446-42 JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
447-ES 209—LS 6921/DI 92 11
448-1 and (c), "isomer" means an optical isomer.
449-2 (b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
450-3 positional, or geometric isomer.
451-4 (c) "Isomer", as used in section 7 of this chapter, means an optical
452-5 or geometric isomer. "Isomer" means an optical, positional, or
453-6 geometric isomer.
454-7 SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.10-2021,
455-8 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
456-9 JULY 1, 2022]: Sec. 4. (a) The controlled substances listed in this
457-10 section are included in schedule I.
458-11 (b) Opiates. Any of the following opiates, including their isomers,
459-12 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
460-13 specifically excepted by rule of the board or unless listed in another
461-14 schedule, whenever the existence of these isomers, esters, ethers, and
462-15 salts is possible within the specific chemical designation:
463-16 4-fluoroisobutyryl fentanyl
464-17 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
465-18 piperidinyl]-N-phenylacetamide) (9815)
466-19 Acetyl fentanyl (Other names include:
467-20 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
468-21 Acetylmethadol (9601)
469-22 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
470-23 N-phenylacrylamide
471-24 Allylprodine (9602)
472-25 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
473-26 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
474-27 Alphacetylmethadol (9603)
475-28 Alphameprodine (9604)
476-29 Alphamethadol (9605)
477-30 Alphamethylfentanyl (9814)
478-31 Benzethidine (9606)
479-32 Beta-hydroxy-3-methylfentanyl (9831). Other name:
480-33 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
481-34 ]-N-phenylpropanamide
482-35 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
483-36 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
484-37 Betacetylmethadol (9607)
485-38 Betameprodine (9608)
486-39 Betamethadol (9609)
487-40 Betaprodine (9611)
488-41 Brorphine
489-42 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-di
490-ES 209—LS 6921/DI 92 12
491-1 ethylethan-1-amine (butonitazene)
492-2 Clonitazene (9612)
493-3 Cyclopentyl fentanyl. Other name:
494-4 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
495-5 Dextromoramide (9613)
496-6 Diampromide (9615)
497-7 Diethylthiambutene (9616)
498-8 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-
499-9 1-yl)ethan-1-amine (flunitazene)
500-10 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)e
501-11 than-1-amine (metodesnitazene)
502-12 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidaz
503-13 ol-1-yl)ethan-1-amine (metonitazene)
504-14 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidaz
505-15 ol-1-yl)ethan-1-amine (protonitazene)
506-16 Difenoxin (9168)
507-17 Dimenoxadol (9617)
508-18 Dimepheptanol (9618)
509-19 Dimethylthiambutene (9619)
510-20 Dioxaphetyl butyrate (9621)
511-21 Dipipanone (9622)
512-22 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethyleth
513-23 an-1-amine (etodesnitazene; etazene)
514-24 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
515-25 benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)
516-26 Ethylmethylthiambutene (9623)
517-27 Etonitazene (9624)
518-28 Etoxeridine (9625)
519-29 Fentanyl related substances.
520-30 Furanyl fentanyl.
521-31 Furethidine (9626)
522-32 Hydroxypethidine (9627)
523-33 Isobutyryl fentanyl. Other name:
524-34 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
525-35 Isotonitazene. Other name: N,N-diethyl-2-
526-36 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
527-37 1-yl)ethan-1-amine)
528-38 Ketobemidone (9628)
529-39 Levomoramide (9629)
530-40 Levophenacylmorphan (9631)
531-41 Methoxyacetyl fentanyl. Other name:
532-42 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
533-ES 209—LS 6921/DI 92 13
534-1 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
535-2 piperidyl]-N-phenyl-propanimide](9813)
536-3 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
537-4 piperidinyl]-N-phenylpropanamide) (9833)
538-5 MDMB-4en-PINACA
539-6 4F-MDMB-BICA; 4-fluoro MDMB-BICA; 4F-MDMB-BUTICA;
540-7 Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,
541-8 3-dimethyl-butanoate
542-9 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
543-10 Morpheridine (9632)
544-11 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
545-12 including any isomers, salts, or salts of isomers (9818)
546-13 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
547-14 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
548-15 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
549-16 (beta-hydroxythiofentanyl)
550-17 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
551-18 (para-chloroisobutyryl fentanyl)
552-19 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
553-20 acetamide (ocfentanil)
554-21 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
555-22 (para-fluorobutyryl fentanyl)
556-23 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
557-24 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
558-25 fentanyl)
559-26 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
560-27 fentanyl)
561-28 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
562-29 (para-methoxybutyryl fentanyl)
563-30 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
564-31 (thenylfentanyl), including any isomers, salts, or salts of isomers
565-32 (9834)
566-33 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
567-34 fentanyl)
568-35 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
569-36 (cyclopentyl fentanyl)
570-37 Noracymethadol (9633)
571-38 Norlevorphanol (9634)
572-39 Normethadone (9635)
573-40 Norpipanone (9636)
574-41 Ocfentanil. Other name:
575-42 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
576-ES 209—LS 6921/DI 92 14
577-1 acetamide
578-2 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
579-3 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
580-4 Para-chloroisobutyryl fentanyl. Other name:
416+22 (6) Any compound structurally derived from
417+23 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
418+24 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
419+25 cycloalkylmethyl, cycloalkylethyl,
420+26 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
421+27 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
422+28 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
423+29 or not substituted in the cyclohexyl ring to any extent.
424+30 (7) Any compound containing a 3-(benzoyl)indole structure with
425+31 substitution at the nitrogen atom of the indole ring by alkyl,
426+32 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
427+33 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
428+34 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
429+35 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
430+36 or not further substituted in the indole ring to any extent and
431+37 whether or not substituted in the phenyl ring to any extent.
432+38 (8) Any compound, except bupropion or a compound listed under
433+39 a different schedule, structurally derived from
434+40 2-aminopropan-1-one by substitution at the 1-position with either
435+41 phenyl, naphthyl, or thiophene ring systems, whether or not the
436+42 compound is further modified:
437+SB 209—LS 6921/DI 92 11
438+1 (A) by substitution in the ring system to any extent with alkyl,
439+2 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
440+3 substituents, whether or not further substituted in the ring
441+4 system by one or more other univalent substituents;
442+5 (B) by substitution at the 3-position with an acyclic alkyl
443+6 substituent;
444+7 (C) by substitution at the 2-amino nitrogen atom with alkyl,
445+8 dialkyl, benzyl, or methoxybenzyl groups; or
446+9 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
447+10 structure.
448+11 (9) Any compound structurally derived from 3-tetramethyl
449+12 cyclopropanoylindole with substitution at the nitrogen atom of the
450+13 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
451+14 cycloalkylmethyl, cycloalkylethyl,
452+15 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
453+16 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
454+17 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
455+18 or not further substituted in the indole ring to any extent and
456+19 whether or not substituted in the tetramethylcyclopropyl ring to
457+20 any extent.
458+21 (10) Any compound containing a N-(1-adamantyl)-
459+22 1H-indazole-3-carboxamide structure with substitution at the
460+23 nitrogen atom of the indazole ring by an alkyl, haloalkyl,
461+24 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
462+25 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
463+26 1-(N-methyl-2-pyrrolidinyl)methyl,
464+27 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
465+28 group, whether or not further substituted at the nitrogen atom of
466+29 the carboxamide to any extent, whether or not further substituted
467+30 in the indazole ring to any extent, and whether or not further
468+31 substituted on the adamantyl ring system to any extent. An
469+32 example of this structural class includes AKB48.
470+33 (11) Any compound containing a N-(1-adamantyl)-
471+34 1H-indole-3-carboxamide structure with substitution at the
472+35 nitrogen atom of the indole ring by an alkyl, haloalkyl,
473+36 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
474+37 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
475+38 1-(N-methyl-2-pyrrolidinyl)methyl,
476+39 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
477+40 group, whether or not further substituted at the nitrogen atom of
478+41 the carboxamide to any extent, whether or not further substituted
479+42 in the indole ring to any extent, and whether or not further
480+SB 209—LS 6921/DI 92 12
481+1 substituted on the adamantyl ring system to any extent. An
482+2 example of this structural class includes STS-135.
483+3 (12) Any compound containing a 3-(1-adamantoyl)indole
484+4 structure with substitution at the nitrogen atom of the indole ring
485+5 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
486+6 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
487+7 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
488+8 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
489+9 group, whether or not further substituted on the adamantyl ring
490+10 system to any extent. An example of this structural class includes
491+11 AM-1248.
492+12 (13) Any compound determined to be a synthetic drug by rule
493+13 adopted under IC 25-26-13-4.1.
494+14 SECTION 5. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
495+15 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
496+16 JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
497+17 and (c), "isomer" means an optical isomer.
498+18 (b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
499+19 positional, or geometric isomer.
500+20 (c) "Isomer", as used in section 7 of this chapter, means an optical
501+21 or geometric isomer. "Isomer" means an optical, positional, or
502+22 geometric isomer.
503+23 SECTION 6. IC 35-48-1-17.5, AS AMENDED BY P.L.190-2019,
504+24 SECTION 28, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
505+25 JULY 1, 2022]: Sec. 17.5. (a) "Low THC hemp extract" means a
506+26 substance or compound that:
507+27 (1) is derived from or contains any part of the plant Cannabis
508+28 sativa L. that meets the definition of hemp under IC 15-15-13-6;
509+29 (2) contains not more than three-tenths percent (0.3%) total
510+30 delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
511+31 including precursors and isomers, by weight; and
512+32 (3) contains no other controlled substances.
513+33 (b) The term does not include:
514+34 (1) the harvested reproductive organ, whether immature or
515+35 mature, of the female hemp plant; or
516+36 (2) smokable hemp.
517+37 SECTION 7. IC 35-48-2-4, AS AMENDED BY P.L.10-2021,
518+38 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
519+39 JULY 1, 2022]: Sec. 4. (a) The controlled substances listed in this
520+40 section are included in schedule I.
521+41 (b) Opiates. Any of the following opiates, including their isomers,
522+42 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
523+SB 209—LS 6921/DI 92 13
524+1 specifically excepted by rule of the board or unless listed in another
525+2 schedule, whenever the existence of these isomers, esters, ethers, and
526+3 salts is possible within the specific chemical designation:
527+4 4-fluoroisobutyryl fentanyl
528+5 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
529+6 piperidinyl]-N-phenylacetamide) (9815)
530+7 Acetyl fentanyl (Other names include:
531+8 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
532+9 Acetylmethadol (9601)
533+10 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
534+11 N-phenylacrylamide
535+12 Allylprodine (9602)
536+13 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
537+14 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
538+15 Alphacetylmethadol (9603)
539+16 Alphameprodine (9604)
540+17 Alphamethadol (9605)
541+18 Alphamethylfentanyl (9814)
542+19 Benzethidine (9606)
543+20 Beta-hydroxy-3-methylfentanyl (9831). Other name:
544+21 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
545+22 ]-N-phenylpropanamide
546+23 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
547+24 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
548+25 Betacetylmethadol (9607)
549+26 Betameprodine (9608)
550+27 Betamethadol (9609)
551+28 Betaprodine (9611)
552+29 Brorphine
553+30 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-di
554+31 ethylethan-1-amine (butonitazene)
555+32 Clonitazene (9612)
556+33 Cyclopentyl fentanyl. Other name:
557+34 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
558+35 Dextromoramide (9613)
559+36 Diampromide (9615)
560+37 Diethylthiambutene (9616)
561+38 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-
562+39 1-yl)ethan-1-amine (flunitazene)
563+40 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)e
564+41 than-1-amine (metodesnitazene)
565+42 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidaz
566+SB 209—LS 6921/DI 92 14
567+1 ol-1-yl)ethan-1-amine (metonitazene)
568+2 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidaz
569+3 ol-1-yl)ethan-1-amine (protonitazene)
570+4 Difenoxin (9168)
571+5 Dimenoxadol (9617)
572+6 Dimepheptanol (9618)
573+7 Dimethylthiambutene (9619)
574+8 Dioxaphetyl butyrate (9621)
575+9 Dipipanone (9622)
576+10 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethyleth
577+11 an-1-amine (etodesnitazene; etazene)
578+12 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
579+13 benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)
580+14 Ethylmethylthiambutene (9623)
581+15 Etonitazene (9624)
582+16 Etoxeridine (9625)
583+17 Fentanyl related substances.
584+18 Furanyl fentanyl.
585+19 Furethidine (9626)
586+20 Hydroxypethidine (9627)
587+21 Isobutyryl fentanyl. Other name:
588+22 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
589+23 Isotonitazene. Other name: N,N-diethyl-2-
590+24 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
591+25 1-yl)ethan-1-amine)
592+26 Ketobemidone (9628)
593+27 Levomoramide (9629)
594+28 Levophenacylmorphan (9631)
595+29 Methoxyacetyl fentanyl. Other name:
596+30 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
597+31 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
598+32 piperidyl]-N-phenyl-propanimide](9813)
599+33 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
600+34 piperidinyl]-N-phenylpropanamide) (9833)
601+35 MDMB-4en-PINACA
602+36 4F-MDMB-BICA; 4-fluoro MDMB-BICA; 4F-MDMB-BUTICA;
603+37 Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,
604+38 3-dimethyl-butanoate
605+39 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
606+40 Morpheridine (9632)
607+41 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
608+42 including any isomers, salts, or salts of isomers (9818)
609+SB 209—LS 6921/DI 92 15
610+1 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
611+2 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
612+3 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
613+4 (beta-hydroxythiofentanyl)
581614 5 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
582-6 Para-fluorobutyryl fentanyl. Other name:
583-7 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
584-8 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
585-9 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
586-10 Para-methoxybutyryl fentanyl. Other name:
587-11 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
588-12 Phenadoxone (9637)
589-13 Phenampromide (9638)
590-14 Phenomorphan (9647)
591-15 Phenoperidine (9641)
592-16 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
593-17 Piritramide (9642)
594-18 Proheptazine (9643)
595-19 Properidine (9644)
596-20 Propiram (9649)
597-21 Racemoramide (9645)
598-22 Tetrahydrofuranyl fentanyl. Other name:
599-23 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
600-24 oxamide
601-25 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
602-26 piperidinyl]-propanamide) (9835)
603-27 Tilidine (9750)
604-28 Trimeperidine (9646)
605-29 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
606-30 N-methyl- benzamide)
607-31 Valeryl fentanyl. Other name:
608-32 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
609-33 (c) Opium derivatives. Any of the following opium derivatives, their
610-34 salts, isomers, and salts of isomers, unless specifically excepted by rule
611-35 of the board or unless listed in another schedule, whenever the
612-36 existence of these salts, isomers, and salts of isomers is possible within
613-37 the specific chemical designation:
614-38 Acetorphine (9319)
615-39 Acetyldihydrocodeine (9051)
616-40 Benzylmorphine (9052)
617-41 Codeine methylbromide (9070)
618-42 Codeine-N-Oxide (9053)
619-ES 209—LS 6921/DI 92 15
620-1 Cyprenorphine (9054)
621-2 Desomorphine (9055)
622-3 Dihydromorphine (9145)
623-4 Drotebanol (9335)
624-5 Etorphine (except hydrochloride salt) (9056)
625-6 Heroin (9200)
626-7 Hydromorphinol (9301)
627-8 Methyldesorphine (9302)
628-9 Methyldihydromorphine (9304)
629-10 Morphine methylbromide (9305)
630-11 Morphine methylsulfonate (9306)
631-12 Morphine-N-Oxide (9307)
632-13 Myrophine (9308)
633-14 Nicocodeine (9309)
634-15 Nicomorphine (9312)
635-16 Normorphine (9313)
636-17 Pholcodine (9314)
637-18 Thebacon (9315)
638-19 (d) Hallucinogenic substances. Unless specifically excepted or
639-20 unless listed in another schedule, any material, compound, mixture, or
640-21 preparation which contains any quantity of the following
641-22 hallucinogenic, psychedelic, or psychogenic substances, their salts,
642-23 isomers, and salts of isomers whenever the existence of these salts,
643-24 isomers, and salts of isomers is possible within the specific chemical
644-25 designation (for purposes of this subsection only, the term "isomer"
645-26 includes the optical, position, and geometric isomers): designation:
646-27 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
647-28 TCPy.
648-29 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
649-30 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
650-31 4-Bromo-2, 5-DMA.
651-32 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
652-33 or other names:
653-34 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
654-35 alpha-desmethyl DOB; 2C-B, Nexus.
655-36 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
656-37 DOET.
657-38 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
658-39 Other name: 2C-T-7.
659-40 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
660-41 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
661-42 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
662-ES 209—LS 6921/DI 92 16
663-1 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
664-2 PMA.
665-3 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
666-4 Name: MMDA.
667-5 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
668-6 isomers, salts, or salts of isomers (7439). Other name:
669-7 5-MeO-DIPT.
670-8 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
671-9 and other names: 4-methyl-2,
672-10 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
673-11 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
674-12 MDA.
675-13 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
676-14 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
677-15 phenethylamine; N-ethyl MDA; MDE; and MDEA.
678-16 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
679-17 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
680-18 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
681-19 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
682-20 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
683-21 (16) Alpha-methyltryptamine (7432). Other name: AMT.
684-22 (17) Bufotenine (7433). Some trade and other names:
685-23 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
686-24 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
687-25 5-hydroxy-N, N-dimethyltryptamine; mappine.
688-26 (18) Diethyltryptamine (7434). Some trade or other names: N,
689-27 N-Diethyltryptamine; DET.
690-28 (19) Dimethyltryptamine (7435). Some trade or other names:
691-29 DMT.
692-30 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
693-31 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
694-32 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
695-33 (21) Lysergic acid diethylamide (7315). Other name: LSD.
696-34 (22) Marijuana (7360).
697-35 (23) Mescaline (7381).
698-36 (24) Parahexyl (7374). Some trade or other names:
699-37 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
700-38 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
701-39 (25) Peyote (7415), including:
702-40 (A) all parts of the plant that are classified botanically as
703-41 lophophora williamsii lemaire, whether growing or not;
704-42 (B) the seeds thereof;
705-ES 209—LS 6921/DI 92 17
706-1 (C) any extract from any part of the plant; and
707-2 (D) every compound, manufacture, salt, derivative, mixture, or
708-3 preparation of the plant, its seeds, or extracts.
709-4 (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
710-5 (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
711-6 names: N-hydroxy-alpha-methyl-3,4
712-7 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
713-8 (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
714-9 (29) Psilocybin (7437).
715-10 (30) Psilocyn (7438).
716-11 (31) Tetrahydrocannabinols (7370), including synthetic
717-12 equivalents of the substances contained in the plant, or in the
718-13 resinous extractives of Cannabis, sp. and synthetic substances,
719-14 derivatives, and their isomers with similar chemical structure and
720-15 pharmacological activity such as:
721-16 (A) ð
615+6 (para-chloroisobutyryl fentanyl)
616+7 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
617+8 acetamide (ocfentanil)
618+9 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
619+10 (para-fluorobutyryl fentanyl)
620+11 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
621+12 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
622+13 fentanyl)
623+14 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
624+15 fentanyl)
625+16 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
626+17 (para-methoxybutyryl fentanyl)
627+18 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
628+19 (thenylfentanyl), including any isomers, salts, or salts of isomers
629+20 (9834)
630+21 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
631+22 fentanyl)
632+23 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
633+24 (cyclopentyl fentanyl)
634+25 Noracymethadol (9633)
635+26 Norlevorphanol (9634)
636+27 Normethadone (9635)
637+28 Norpipanone (9636)
638+29 Ocfentanil. Other name:
639+30 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
640+31 acetamide
641+32 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
642+33 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
643+34 Para-chloroisobutyryl fentanyl. Other name:
644+35 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
645+36 Para-fluorobutyryl fentanyl. Other name:
646+37 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
647+38 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
648+39 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
649+40 Para-methoxybutyryl fentanyl. Other name:
650+41 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
651+42 Phenadoxone (9637)
652+SB 209—LS 6921/DI 92 16
653+1 Phenampromide (9638)
654+2 Phenomorphan (9647)
655+3 Phenoperidine (9641)
656+4 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
657+5 Piritramide (9642)
658+6 Proheptazine (9643)
659+7 Properidine (9644)
660+8 Propiram (9649)
661+9 Racemoramide (9645)
662+10 Tetrahydrofuranyl fentanyl. Other name:
663+11 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
664+12 oxamide
665+13 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
666+14 piperidinyl]-propanamide) (9835)
667+15 Tilidine (9750)
668+16 Trimeperidine (9646)
669+17 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
670+18 N-methyl- benzamide)
671+19 Valeryl fentanyl. Other name:
672+20 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
673+21 (c) Opium derivatives. Any of the following opium derivatives, their
674+22 salts, isomers, and salts of isomers, unless specifically excepted by rule
675+23 of the board or unless listed in another schedule, whenever the
676+24 existence of these salts, isomers, and salts of isomers is possible within
677+25 the specific chemical designation:
678+26 Acetorphine (9319)
679+27 Acetyldihydrocodeine (9051)
680+28 Benzylmorphine (9052)
681+29 Codeine methylbromide (9070)
682+30 Codeine-N-Oxide (9053)
683+31 Cyprenorphine (9054)
684+32 Desomorphine (9055)
685+33 Dihydromorphine (9145)
686+34 Drotebanol (9335)
687+35 Etorphine (except hydrochloride salt) (9056)
688+36 Heroin (9200)
689+37 Hydromorphinol (9301)
690+38 Methyldesorphine (9302)
691+39 Methyldihydromorphine (9304)
692+40 Morphine methylbromide (9305)
693+41 Morphine methylsulfonate (9306)
694+42 Morphine-N-Oxide (9307)
695+SB 209—LS 6921/DI 92 17
696+1 Myrophine (9308)
697+2 Nicocodeine (9309)
698+3 Nicomorphine (9312)
699+4 Normorphine (9313)
700+5 Pholcodine (9314)
701+6 Thebacon (9315)
702+7 (d) Hallucinogenic substances. Unless specifically excepted or
703+8 unless listed in another schedule, any material, compound, mixture, or
704+9 preparation which contains any quantity of the following
705+10 hallucinogenic, psychedelic, or psychogenic substances, their salts,
706+11 isomers, and salts of isomers whenever the existence of these salts,
707+12 isomers, and salts of isomers is possible within the specific chemical
708+13 designation (for purposes of this subsection only, the term "isomer"
709+14 includes the optical, position, and geometric isomers): designation:
710+15 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
711+16 TCPy.
712+17 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
713+18 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
714+19 4-Bromo-2, 5-DMA.
715+20 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
716+21 or other names:
717+22 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
718+23 alpha-desmethyl DOB; 2C-B, Nexus.
719+24 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
720+25 DOET.
721+26 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
722+27 Other name: 2C-T-7.
723+28 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
724+29 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
725+30 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
726+31 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
727+32 PMA.
728+33 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
729+34 Name: MMDA.
730+35 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
731+36 isomers, salts, or salts of isomers (7439). Other name:
732+37 5-MeO-DIPT.
733+38 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
734+39 and other names: 4-methyl-2,
735+40 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
736+41 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
737+42 MDA.
738+SB 209—LS 6921/DI 92 18
739+1 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
740+2 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
741+3 phenethylamine; N-ethyl MDA; MDE; and MDEA.
742+4 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
743+5 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
744+6 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
745+7 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
746+8 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
747+9 (16) Alpha-methyltryptamine (7432). Other name: AMT.
748+10 (17) Bufotenine (7433). Some trade and other names:
749+11 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
750+12 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
751+13 5-hydroxy-N, N-dimethyltryptamine; mappine.
752+14 (18) Diethyltryptamine (7434). Some trade or other names: N,
753+15 N-Diethyltryptamine; DET.
754+16 (19) Dimethyltryptamine (7435). Some trade or other names:
755+17 DMT.
756+18 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
757+19 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
758+20 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
759+21 (21) Lysergic acid diethylamide (7315). Other name: LSD.
760+22 (22) Marijuana (7360).
761+23 (23) Mescaline (7381).
762+24 (24) Parahexyl (7374). Some trade or other names:
763+25 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
764+26 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
765+27 (25) Peyote (7415), including:
766+28 (A) all parts of the plant that are classified botanically as
767+29 lophophora williamsii lemaire, whether growing or not;
768+30 (B) the seeds thereof;
769+31 (C) any extract from any part of the plant; and
770+32 (D) every compound, manufacture, salt, derivative, mixture, or
771+33 preparation of the plant, its seeds, or extracts.
772+34 (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
773+35 (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
774+36 names: N-hydroxy-alpha-methyl-3,4
775+37 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
776+38 (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
777+39 (29) Psilocybin (7437).
778+40 (30) Psilocyn (7438).
779+41 (31) Tetrahydrocannabinols (7370), including synthetic
780+42 equivalents of the substances contained in the plant, or in the
781+SB 209—LS 6921/DI 92 19
782+1 resinous extractives of Cannabis, sp. and synthetic substances,
783+2 derivatives, and their isomers with similar chemical structure and
784+3 pharmacological activity such as:
785+4 (A) ð
722786 1
723787 cis or trans tetrahydrocannabinol, and their optical
724-17 isomers;
725-18 (B) ð
788+5 isomers;
789+6 (B) ð
726790 6
727791 cis or trans tetrahydrocannabinol, and their optical
728-19 isomers; and
729-20 (C) ð
792+7 isomers; and
793+8 (C) ð
730794 3,
731795 4 cis or trans tetrahydrocannabinol, and their optical
732-21 isomers.
733-22 Since nomenclature of these substances is not internationally
734-23 standardized, compounds of these structures, regardless of
735-24 numerical designation of atomic positions are covered. Other
736-25 name: THC.
737-26 (32) Ethylamine analog of phencyclidine (7455). Some trade or
738-27 other names: N-Ethyl-1-phenylcyclohexylamine;
739-28 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
740-29 ethylamine; cyclohexamine; PCE.
741-30 (33) Pyrrolidine analog of phencyclidine (7458). Some trade or
742-31 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
796+9 isomers.
797+10 Since nomenclature of these substances is not internationally
798+11 standardized, compounds of these structures, regardless of
799+12 numerical designation of atomic positions are covered. Other
800+13 name: THC.
801+14 (32) Ethylamine analog of phencyclidine (7455). Some trade or
802+15 other names: N-Ethyl-1-phenylcyclohexylamine;
803+16 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
804+17 ethylamine; cyclohexamine; PCE.
805+18 (33) Pyrrolidine analog of phencyclidine (7458). Some trade or
806+19 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
743807 y; PHP.
744-32 (34) Thiophene analog of phencyclidine (7470). Some trade or
745-33 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
746-34 Analog of Phencyclidine; TPCP.
747-35 (35) Salvia divinorum or salvinorin A, including:
748-36 (A) all parts of the plant that are classified botanically as salvia
749-37 divinorum, whether growing or not;
750-38 (B) the seeds of the plant;
751-39 (C) any extract from any part of the plant; and
752-40 (D) every compound, manufacture, salt, derivative, mixture, or
753-41 preparation of the plant, its seeds, or extracts.
754-42 (36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
755-ES 209—LS 6921/DI 92 18
756-1 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
757-2 5-MeO-DMT.
758-3 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
759-4 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
760-5 (39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
761-6 (40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
762-7 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
763-8 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
764-9 (2C-T-4).
765-10 (43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
766-11 (44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
767-12 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
768-13 (46) Deschloroketamine (2-Phenyl-2-
769-14 (methylamino)cyclohexanone).
770-15 (47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
771-16 ethyltryptamine).
772-17 (48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
773-18 (e) Depressants. Unless specifically excepted in a rule adopted by
774-19 the board or unless listed in another schedule, any material, compound,
775-20 mixture, or preparation which contains any quantity of the following
776-21 substances having a depressant effect on the central nervous system,
777-22 including its salts, isomers, and salts of isomers whenever the existence
778-23 of such salts, isomers, and salts of isomers is possible within the
779-24 specific chemical designation:
780-25 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
781-26 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
782-27 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
783-28 Pasaden)
784-29 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
785-30 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
786-31 Gamma-hydroxybutyric acid (other names include GHB;
787-32 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
788-33 oxybate; sodium oxybutyrate) (2010)
789-34 Mecloqualone (2572)
790-35 Methaqualone (2565)
791-36 (f) Stimulants. Unless specifically excepted or unless listed in
792-37 another schedule, any material, compound, mixture, or preparation that
793-38 contains any quantity of the following substances having a stimulant
794-39 effect on the central nervous system, including its salts, isomers, and
795-40 salts of isomers:
796-41 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
797-42 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
798-ES 209—LS 6921/DI 92 19
799-1 Aminorex (1585). Other names: aminoxaphen;
800-2 2-amino-5-phenyl-2-oxazoline; or
801-3 4,5-dihydro-5-phenyl-2-oxazolamine.
802-4 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
803-5 -1-one. Synonyms: BMDP, N-benzyl methylone,
804-6 3,4-Methylenedioxy-Nbenzylcathinone,
805-7 N-benzyl-3,4-methylenedioxycathinone.
806-8 Cathinone (1235). Some trade or other names:
807-9 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
808-10 2-aminopropiophenone; and norephedrone.
809-11 Fenethylline (1503).
810-12 N-Benzylpiperazine (7493). Other names: BZP; and
811-13 1-benzylpiperazine.
812-14 N-ethylamphetamine (1475).
813-15 Methcathinone (1237). Some other trade names:
814-16 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
815-17 Monomethylpropion; UR 1431.
816-18 N, N-dimethylamphetamine (1480). Other names: N,
817-19 N-alpha-trimethyl-benzeneethanamine; and N,
818-20 N-alpha-trimethylphenethylamine.
819-21 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
820-22 SECTION 4. [EFFECTIVE UPON PASSAGE] (a) The legislative
821-23 council is urged to assign to the interim study committee on
822-24 corrections and criminal code, during the 2022 legislative interim,
823-25 the task of studying "delta-8 THC" and any of its related
824-26 psychoactive cannabinoids.
825-27 (b) This SECTION expires January 1, 2023.
826-28 SECTION 5. An emergency is declared for this act.
827-ES 209—LS 6921/DI 92 20
808+20 (34) Thiophene analog of phencyclidine (7470). Some trade or
809+21 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
810+22 Analog of Phencyclidine; TPCP.
811+23 (35) Salvia divinorum or salvinorin A, including:
812+24 (A) all parts of the plant that are classified botanically as salvia
813+25 divinorum, whether growing or not;
814+26 (B) the seeds of the plant;
815+27 (C) any extract from any part of the plant; and
816+28 (D) every compound, manufacture, salt, derivative, mixture, or
817+29 preparation of the plant, its seeds, or extracts.
818+30 (36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
819+31 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
820+32 5-MeO-DMT.
821+33 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
822+34 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
823+35 (39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
824+36 (40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
825+37 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
826+38 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
827+39 (2C-T-4).
828+40 (43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
829+41 (44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
830+42 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
831+SB 209—LS 6921/DI 92 20
832+1 (46) Deschloroketamine (2-Phenyl-2-
833+2 (methylamino)cyclohexanone).
834+3 (47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
835+4 ethyltryptamine).
836+5 (48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
837+6 (e) Depressants. Unless specifically excepted in a rule adopted by
838+7 the board or unless listed in another schedule, any material, compound,
839+8 mixture, or preparation which contains any quantity of the following
840+9 substances having a depressant effect on the central nervous system,
841+10 including its salts, isomers, and salts of isomers whenever the existence
842+11 of such salts, isomers, and salts of isomers is possible within the
843+12 specific chemical designation:
844+13 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
845+14 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
846+15 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
847+16 Pasaden)
848+17 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
849+18 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
850+19 Gamma-hydroxybutyric acid (other names include GHB;
851+20 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
852+21 oxybate; sodium oxybutyrate) (2010)
853+22 Mecloqualone (2572)
854+23 Methaqualone (2565)
855+24 (f) Stimulants. Unless specifically excepted or unless listed in
856+25 another schedule, any material, compound, mixture, or preparation that
857+26 contains any quantity of the following substances having a stimulant
858+27 effect on the central nervous system, including its salts, isomers, and
859+28 salts of isomers:
860+29 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
861+30 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
862+31 Aminorex (1585). Other names: aminoxaphen;
863+32 2-amino-5-phenyl-2-oxazoline; or
864+33 4,5-dihydro-5-phenyl-2-oxazolamine.
865+34 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
866+35 -1-one. Synonyms: BMDP, N-benzyl methylone,
867+36 3,4-Methylenedioxy-Nbenzylcathinone,
868+37 N-benzyl-3,4-methylenedioxycathinone.
869+38 Cathinone (1235). Some trade or other names:
870+39 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
871+40 2-aminopropiophenone; and norephedrone.
872+41 Fenethylline (1503).
873+42 N-Benzylpiperazine (7493). Other names: BZP; and
874+SB 209—LS 6921/DI 92 21
875+1 1-benzylpiperazine.
876+2 N-ethylamphetamine (1475).
877+3 Methcathinone (1237). Some other trade names:
878+4 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
879+5 Monomethylpropion; UR 1431.
880+6 N, N-dimethylamphetamine (1480). Other names: N,
881+7 N-alpha-trimethyl-benzeneethanamine; and N,
882+8 N-alpha-trimethylphenethylamine.
883+9 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
884+SB 209—LS 6921/DI 92 22
828885 COMMITTEE REPORT
829886 Madam President: The Senate Committee on Corrections and
830887 Criminal Law, to which was referred Senate Bill No. 209, has had the
831888 same under consideration and begs leave to report the same back to the
832889 Senate with the recommendation that said bill be AMENDED as
833890 follows:
834891 Page 1, between the enacting clause and line 1, begin a new
835892 paragraph and insert:
836893 "SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
837894 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
838895 JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
839896 (1) a substance containing one (1) or more of the following
840897 chemical compounds, including an analog of the compound:
841898 (A) JWH-015 ((2-Methyl-1-propyl-1H-
842899 indol-3-yl)-1-naphthalenylmethanone).
843900 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
844901 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
845902 (D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
846903 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
847904 3-yl)methanone).
848905 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
849906 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
850907 naphthalen-1-yl-methanone).
851908 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
852909 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
853910 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
854911 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
855912 3-(2-methyloctan-2-yl)-
856913 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
857914 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
858915 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
859916 [c]chromen-1-ol).
860917 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
861918 (2-methyloctan- 2-yl)phenyl]-
862919 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
863920 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
864921 (1-methylethenyl)-2 -cyclohexen-1-yl]-5
865922 -pentyl-2,5-cyclohexadiene-1,4-dione).
866923 (O) CP 55,940
867924 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
868925 5- (2-methyloctan-2-yl)phenol).
869-ES 209—LS 6921/DI 92 21
926+SB 209—LS 6921/DI 92 23
870927 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
871928 (2-methyloctan-2-yl)phenol) and its homologues, or
872929 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
873930 phenol), where side chain n=5, and homologues where side
874931 chain n=4, 6, or 7.
875932 (Q) WIN 55212-2
876933 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
877934 pyrrolo [1,2,3-de)- 1,4- benzoxazin-
878935 6-yl]-1-napthalenylmethanone).
879936 (R) RCS-4 ((4-methoxyphenyl)
880937 (1-pentyl-1H-indol-3-yl)methanone).
881938 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
882939 indol-3-yl)-2-(2-methoxyphenyl)ethanone).
883940 (T) 4-Methylmethcathinone. Other name: mephedrone.
884941 (U) 3,4-Methylenedioxymethcathinone. Other name:
885942 methylone.
886943 (V) Fluoromethcathinone.
887944 (W) 4-Methoxymethcathinone. Other name: methedrone.
888945 (X) 4-Ethylmethcathinone (4-EMC).
889946 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
890947 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
891948 (AA) JWH-098, or
892949 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
893950 (BB) JWH-164, or
894951 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
895952 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
896953 (DD) JWH-201, or
897954 1-pentyl-3-(4-methoxyphenylacetyl)indole.
898955 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
899956 (FF) AM-694, or
900957 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
901958 (GG) CP 50,556-1, or
902959 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
903960 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
904961 -yl] acetate.
905962 (HH) Dimethylheptylpyran, or DMHP.
906963 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
907964 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
908965 (LL) 7-hydroxymitragynine.
909966 (MM) á-PPP [á-pyrrolidinopropiophenone].
910967 (NN) á-PVP (desmethylpyrovalerone).
911968 (OO) AM-251.
912-ES 209—LS 6921/DI 92 22
969+SB 209—LS 6921/DI 92 24
913970 (PP) AM-1241.
914971 (QQ) AM-2201.
915972 (RR) AM-2233.
916973 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
917974 (TT) Butylone.
918975 (UU) CP-47,497-C7.
919976 (VV) CP-47,497-C8.
920977 (WW) Desoxypipradol.
921978 (XX) Ethylone.
922979 (YY) Eutylone.
923980 (ZZ) Flephedrone.
924981 (AAA) JWH-011.
925982 (BBB) JWH-020.
926983 (CCC) JWH-022.
927984 (DDD) JWH-030.
928985 (EEE) JWH-182.
929986 (FFF) JWH-302.
930987 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
931988 (HHH) Mitragynine.
932989 (III) Naphyrone.
933990 (JJJ) Pentedrone.
934991 (LLL) Pentylone.
935992 (MMM) Methoxetamine
936993 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
937994 (NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
938995 (2,2,3,3-tetramethylcyclopropyl)methanone].
939996 (OOO) AB-001[(1s,3s)-admantan-1-yl)
940997 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
941998 (1-adamantoyl)indole].
942999 (PPP) AM-356 [Methanandamide].
9431000 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
9441001 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
9451002 [(1-[(N-methylpiperindin-2-yl)
9461003 Methyl]-3-(Adamant-1-oyl)indole)].
9471004 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)
9481005 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
9491006 (SSS) CB-13 [1-Naphthalenyl
9501007 [4-(pentyoxy)- 1-naphthalenyl]methanone].
9511008 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
9521009 (2,2,3,3-tetramethylcyclopropyl)-methanone].
9531010 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
9541011 cyclohexylcarbamate].
955-ES 209—LS 6921/DI 92 23
1012+SB 209—LS 6921/DI 92 25
9561013 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
9571014 cyclohexyl ester].
9581015 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
9591016 amino]-1-benzoxazin-4-one].
9601017 (XXX) XLR-11 or 5-fluoro UR-144
9611018 (1-(5-fluoropentyl)-1H-indol-3-yl)
9621019 (2,2,3,3-tetramethylcyclopropyl)methanone].
9631020 (YYY) AKB48 (Other names include:
9641021 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
9651022 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
9661023 carboxamide).
9671024 (ZZZ) 25I-NBOMe (Other names include:
9681025 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
9691026 benzeneethanamine);
9701027 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
9711028 methyl]ethanamine).
9721029 (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
9731030 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
9741031 methyl]ethanamine;
9751032 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
9761033 phenethylamine).
9771034 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
9781035 (1-adamantylamido)indole).
9791036 (CCCC) STS-135 (Other names include:
9801037 N-Adamantyl-1-fluoropentylindole-3- carboxamide
9811038 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
9821039 indole-3-carboxamide).
9831040 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
9841041 ester-1H-indole-2-carboxylic acid).
9851042 (EEEE) 5-Fluoro-PB-22 (Other names include:
9861043 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
9871044 acid).
9881045 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and
9891046 Benzothiophenylcyclohexylpiperidine).
9901047 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
9911048 and 4-Bromo-2,
9921049 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
9931050 benzeneethanamine).
9941051 (HHHH) APB (Other names include: (2-Aminopropyl)
9951052 Benzofuran).
9961053 (IIII) AB-PINACA
9971054 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
998-ES 209—LS 6921/DI 92 24
1055+SB 209—LS 6921/DI 92 26
9991056 indazole-3-carboxamide.
10001057 (JJJJ) AB-FUBINACA
10011058 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
10021059 1H-indazole-3-carboxamide).
10031060 (KKKK) ADB-PINACA
10041061 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
10051062 indaole-3-carboxamide).
10061063 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
10071064 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
10081065 carboxamide).
10091066 (MMMM) APDB (Other names include: -EMA,
10101067 -Desoxy-MDA, and (2-Aminopropyl)-2,3-
10111068 dihydrobenzofuran).
10121069 (NNNN) THJ-2201 (Other names include: AM2201 indazole
10131070 analog, Fluoropentyl-JWH-018 indazole, and
10141071 5-Fluoro-THJ-018).
10151072 (OOOO) AM 2201 benzimidazole analog (Other names
10161073 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
10171074 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
10181075 (PPPP) MN-25 (Other names include: 7-methoxy-1-
10191076 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
10201077 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
10211078 and UR-12).
10221079 (QQQQ) FUB-PB-22 (Other names include:
10231080 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
10241081 (RRRR) FUD-PB-22 (Other names include:
10251082 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
10261083 (SSSS) 5-Fluoro-AB-PINACA (Other names include:
10271084 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
10281085 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
10291086 carboxaminde).
10301087 (TTTT) 4-MePPP (Other names include:
10311088 4-methyl-alpha-pyrrolidinopropiophenone).
10321089 (UUUU) alpha-PBP (Other names include:
10331090 Alpha-pyrrolidinobutiophenone).
10341091 (VVVV) AB-CHMINACA (Other names include:
10351092 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
10361093 l)-1H-indazole-3-carboxamide).
10371094 (WWWW) Mexedrone
10381095 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
10391096 (XXXX) MT-45,
10401097 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
1041-ES 209—LS 6921/DI 92 25
1098+SB 209—LS 6921/DI 92 27
10421099 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
10431100 carboxamido) -3,3-dimethylbutanoate [5F-ADB;
10441101 5F-MDMB-PINACA].
10451102 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
10461103 carboxamido)-3-methylbutanoate [5F-AMB].
10471104 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
10481105 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
10491106 [ADB-FUBINACA].
10501107 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
10511108 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
10521109 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
10531110 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
10541111 MMB-CHMINACA].
10551112 (DDDDD) methyl 2-(1-(4-fluorobenzyl)-
10561113 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
10571114 [MDMB-FUBINACA].
10581115 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
10591116 (cyclohexylmethyl)- 1H-indazole-3-carboxamide
10601117 [MAB-CHMINACA and ADB-CHMINACA].
10611118 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
10621119 3-carboxamido)- 3-methylbutanoate [FUB-AMB,
10631120 MMB-FUBINACA, AMB-FUBINACA].
10641121 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
10651122 thyl]benzamide) [AH7921].
10661123 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
10671124 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
10681125 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
10691126 H-indazole-3-carboxamide (trivial name:
10701127 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
10711128 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
10721129 (JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
10731130 H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
10741131 MMB-CHMICA, AMB-CHMICA).
10751132 (KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
10761133 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
10771134 5F-CUMYL-P7AICA).
10781135 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
10791136 entanone (N-ethylpentylone, ephylone).
10801137 (MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
10811138 (ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
10821139 its optical, positional, and geometric isomers, salts, and salts
10831140 of isomers.
1084-ES 209—LS 6921/DI 92 26
1141+SB 209—LS 6921/DI 92 28
10851142 (NNNNN) ethyl
10861143 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
10871144 dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
10881145 (OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
10891146 carboxamido)-3,3-dimethylbutanoate (trivial name:
10901147 5F-MDMB-PICA).
10911148 (PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
10921149 1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
10931150 FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
10941151 (QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
10951152 1H-indazole-3-carboxamide (trivial names:
10961153 5F-CUMYL-PINACA; SGT-25).
10971154 (RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
10981155 yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
10991156 FUB-144).
11001157 (SSSSS) 4F-MDMB-BINACA.
11011158 (TTTTT) N-ethylhexedrone
11021159 (2-(ethylamino)-1-phenylhexan-1-one).
11031160 (UUUUU) alpha-pyrrolidinohexanophenone
11041161 (1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
11051162 (VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
11061163 a-PHP.
11071164 (WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
11081165 (1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
11091166 (XXXXX) 4-methyl-alphaethylaminopentiophenone
11101167 (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
11111168 name: 4–MEAP.
11121169 (YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
11131170 name: MPHP.
11141171 (ZZZZZ) alphapyrrolidinoheptaphenone
11151172 (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
11161173 (AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
11171174 chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
11181175 (BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
11191176 name: 4-chloro-a-PVP.
11201177 (CCCCCC) 4,4'-dimethylaminorex (common name:
11211178 4,4'-DMAR).
11221179 (2) Any compound structurally derived from
11231180 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
11241181 substitution at the nitrogen atom of the indole ring by alkyl,
11251182 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
11261183 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1127-ES 209—LS 6921/DI 92 27
1184+SB 209—LS 6921/DI 92 29
11281185 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11291186 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
11301187 or not further substituted in the indole ring to any extent and
11311188 whether or not substituted in the naphthyl ring to any extent.
11321189 (3) Any compound structurally derived from 3-(1-naphthoyl)
11331190 pyrrole by substitution at the nitrogen atom of the pyrrole ring by
11341191 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
11351192 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
11361193 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
11371194 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
11381195 group, whether or not further substituted in the pyrrole ring to any
11391196 extent and whether or not substituted in the naphthyl ring to any
11401197 extent.
11411198 (4) Any compound structurally derived from
11421199 1-(1-naphthylmethyl)indene by substitution at the 3-position of
11431200 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
11441201 cycloalkylmethyl, cycloalkylethyl,
11451202 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
11461203 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11471204 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
11481205 or not further substituted in the indene ring to any extent and
11491206 whether or not substituted in the naphthyl ring to any extent.
11501207 (5) Any compound structurally derived from 3-phenylacetylindole
11511208 by substitution at the nitrogen atom of the indole ring with alkyl,
11521209 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
11531210 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
11541211 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11551212 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
11561213 or not further substituted in the indole ring to any extent and
11571214 whether or not substituted in the phenyl ring to any extent.
11581215 (6) Any compound structurally derived from
11591216 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
11601217 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
11611218 cycloalkylmethyl, cycloalkylethyl,
11621219 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
11631220 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11641221 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
11651222 or not substituted in the cyclohexyl ring to any extent.
11661223 (7) Any compound containing a 3-(benzoyl)indole structure with
11671224 substitution at the nitrogen atom of the indole ring by alkyl,
11681225 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
11691226 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1170-ES 209—LS 6921/DI 92 28
1227+SB 209—LS 6921/DI 92 30
11711228 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
11721229 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
11731230 or not further substituted in the indole ring to any extent and
11741231 whether or not substituted in the phenyl ring to any extent.
11751232 (8) Any compound, except bupropion or a compound listed under
11761233 a different schedule, structurally derived from
11771234 2-aminopropan-1-one by substitution at the 1-position with either
11781235 phenyl, naphthyl, or thiophene ring systems, whether or not the
11791236 compound is further modified:
11801237 (A) by substitution in the ring system to any extent with alkyl,
11811238 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
11821239 substituents, whether or not further substituted in the ring
11831240 system by one or more other univalent substituents;
11841241 (B) by substitution at the 3-position with an acyclic alkyl
11851242 substituent;
11861243 (C) by substitution at the 2-amino nitrogen atom with alkyl,
11871244 dialkyl, benzyl, or methoxybenzyl groups; or
11881245 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
11891246 structure.
11901247 (9) Any compound structurally derived from 3-tetramethyl
11911248 cyclopropanoylindole with substitution at the nitrogen atom of the
11921249 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
11931250 cycloalkylmethyl, cycloalkylethyl,
11941251 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
11951252 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
11961253 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
11971254 or not further substituted in the indole ring to any extent and
11981255 whether or not substituted in the tetramethylcyclopropyl ring to
11991256 any extent.
12001257 (10) Any compound containing a N-(1-adamantyl)-
12011258 1H-indazole-3-carboxamide structure with substitution at the
12021259 nitrogen atom of the indazole ring by an alkyl, haloalkyl,
12031260 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
12041261 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
12051262 1-(N-methyl-2-pyrrolidinyl)methyl,
12061263 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
12071264 group, whether or not further substituted at the nitrogen atom of
12081265 the carboxamide to any extent, whether or not further substituted
12091266 in the indazole ring to any extent, and whether or not further
12101267 substituted on the adamantyl ring system to any extent. An
12111268 example of this structural class includes AKB48.
12121269 (11) Any compound containing a N-(1-adamantyl)-
1213-ES 209—LS 6921/DI 92 29
1270+SB 209—LS 6921/DI 92 31
12141271 1H-indole-3-carboxamide structure with substitution at the
12151272 nitrogen atom of the indole ring by an alkyl, haloalkyl,
12161273 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
12171274 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
12181275 1-(N-methyl-2-pyrrolidinyl)methyl,
12191276 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
12201277 group, whether or not further substituted at the nitrogen atom of
12211278 the carboxamide to any extent, whether or not further substituted
12221279 in the indole ring to any extent, and whether or not further
12231280 substituted on the adamantyl ring system to any extent. An
12241281 example of this structural class includes STS-135.
12251282 (12) Any compound containing a 3-(1-adamantoyl)indole
12261283 structure with substitution at the nitrogen atom of the indole ring
12271284 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
12281285 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
12291286 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
12301287 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
12311288 group, whether or not further substituted on the adamantyl ring
12321289 system to any extent. An example of this structural class includes
12331290 AM-1248.
12341291 (13) Any compound determined to be a synthetic drug by rule
12351292 adopted under IC 25-26-13-4.1.
12361293 SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
12371294 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
12381295 JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
12391296 and (c), "isomer" means an optical isomer.
12401297 (b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
12411298 positional, or geometric isomer.
12421299 (c) "Isomer", as used in section 7 of this chapter, means an optical
12431300 or geometric isomer. "Isomer" means an optical, positional, or
12441301 geometric isomer.".
12451302 Page 2, between lines 17 and 18, begin a new line block indented
12461303 and insert:
12471304 "Brorphine".
12481305 Page 2, delete line 42, begin a new line block indented, and insert:
12491306 "2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
12501307 benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)".
12511308 Page 3, delete line 1.
12521309 Page 6, strike line 1.
1253-ES 209—LS 6921/DI 92 30
1310+SB 209—LS 6921/DI 92 32
12541311 Page 6, line 2, strike "includes the optical, position, and geometric
12551312 isomers):" and insert "designation:".
12561313 Renumber all SECTIONS consecutively.
12571314 and when so amended that said bill do pass.
12581315 (Reference is to SB 209 as introduced.)
12591316 YOUNG M, Chairperson
12601317 Committee Vote: Yeas 8, Nays 0.
12611318 _____
12621319 SENATE MOTION
12631320 Madam President: I move that Senate Bill 209 be amended to read
12641321 as follows:
12651322 Page 1, between the enacting clause and line 1, begin a new
12661323 paragraph and insert:
12671324 "SECTION 1. IC 15-15-13-6.5, AS ADDED BY P.L.190-2019,
12681325 SECTION 7, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
12691326 JULY 1, 2022]: Sec. 6.5. As used in this chapter, "hemp product"
12701327 means a product derived from, or made by, processing hemp plants or
12711328 plant parts including derivatives, extracts, cannabinoids, isomers, acids,
12721329 salts, and salts of isomers. However, the term does not include:
12731330 (1) smokable hemp (as defined by IC 35-48-1-26.6); or
12741331 (2) products that contain a total delta-9-tetrahydrocannabinol
12751332 tetrahydrocannabinol concentration of more than three-tenths
12761333 of one percent (0.3%) by weight.
12771334 SECTION 2. IC 24-4-21-3, AS AMENDED BY P.L.190-2019,
12781335 SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
12791336 JULY 1, 2022]: Sec. 3. A person may distribute low THC hemp extract
12801337 in Indiana only if the distributor has a certificate of analysis prepared
12811338 by an independent testing laboratory showing:
12821339 (1) that the low THC hemp extract is the product of a batch tested
12831340 by the independent testing laboratory;
12841341 (2) that the independent testing laboratory determined that the
12851342 batch contained not more than three-tenths percent (0.3%) total
12861343 delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
12871344 including precursors and isomers, by weight, based on the testing
12881345 of a random sample of the batch; and
12891346 (3) the cannabidiol percent present of the low THC hemp extract.
1290-ES 209—LS 6921/DI 92 31
1347+SB 209—LS 6921/DI 92 33
12911348 SECTION 3. IC 24-4-21-4, AS ADDED BY P.L.153-2018,
12921349 SECTION 9, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
12931350 JULY 1, 2022]: Sec. 4. (a) Except as provided in subsection (b), low
12941351 THC hemp extract must be distributed in packaging that contains the
12951352 following information:
12961353 (1) A scannable bar code or QR code linked to a document that
12971354 contains information with respect to THE manufacture of the low
12981355 THC hemp extract, including the:
12991356 (A) batch identification number;
13001357 (B) product name;
13011358 (C) batch date;
13021359 (D) expiration date, which must be not more than two (2) years
13031360 from the date of manufacture;
13041361 (E) batch size;
13051362 (F) total quantity produced;
13061363 (G) ingredients used, including the:
13071364 (i) ingredient name;
13081365 (ii) name of the company that manufactured the ingredient;
13091366 (iii) company or product identification number or code, if
13101367 applicable; and
13111368 (iv) ingredient lot number; and
13121369 (H) download link for a certificate of analysis for the low THC
13131370 hemp extract.
13141371 (2) The batch number.
13151372 (3) The Internet address of a web site to obtain batch information.
13161373 (4) The expiration date.
13171374 (5) The number of milligrams of low THC hemp extract.
13181375 (6) The manufacturer.
13191376 (7) The fact that the product contains not more than three-tenths
13201377 percent (0.3%) total delta-9-tetrahydrocannabinol
13211378 tetrahydrocannabinol (THC), including precursors and isomers,
13221379 by weight.
13231380 (b) Before July 1, 2018, low THC hemp extract may be distributed
13241381 in Indiana without having met the requirements described in subsection
13251382 (a).".
13261383 Page 1, line 5, delete "compound:" and insert "compound and its
13271384 isomers, salts, and salts of isomers:".
13281385 Page 11, between lines 5 and 6, begin a new paragraph and insert:
13291386 "SECTION 6. IC 35-48-1-17.5, AS AMENDED BY P.L.190-2019,
13301387 SECTION 28, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
13311388 JULY 1, 2022]: Sec. 17.5. (a) "Low THC hemp extract" means a
13321389 substance or compound that:
1333-ES 209—LS 6921/DI 92 32
1390+SB 209—LS 6921/DI 92 34
13341391 (1) is derived from or contains any part of the plant Cannabis
13351392 sativa L. that meets the definition of hemp under IC 15-15-13-6;
13361393 (2) contains not more than three-tenths percent (0.3%) total
13371394 delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
13381395 including precursors and isomers, by weight; and
13391396 (3) contains no other controlled substances.
13401397 (b) The term does not include:
13411398 (1) the harvested reproductive organ, whether immature or
13421399 mature, of the female hemp plant; or
13431400 (2) smokable hemp.".
13441401 Renumber all SECTIONS consecutively.
13451402 (Reference is to SB 209 as printed January 21, 2022.)
13461403 BROWN L
1347-_____
1348-SENATE MOTION
1349-Madam President: I move that Engrossed Senate Bill 209, which is
1350-eligible for third reading, be returned to second reading for purposes of
1351-amendment.
1352-YOUNG M
1353-_____
1354-SENATE MOTION
1355-Madam President: I move that Senate Bill 209 be amended to read
1356-as follows:
1357-Page 21, after line 9, begin a new paragraph and insert:
1358-"SECTION 8. IC 35-48-4-18 IS ADDED TO THE INDIANA CODE
1359-AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
1360-1, 2022]: Sec. 18. (a) This section applies to the following offenses:
1361-(1) Dealing in a schedule I, II, or III controlled substance
1362-under section 2 of this chapter.
1363-(2) Possession of a controlled substance under section 7 of this
1364-chapter.
1365-(3) Dealing in marijuana, hash oil, or hashish under section 10
1366-of this chapter.
1367-(4) Possession of marijuana, hash oil, or hashish under section
1368-ES 209—LS 6921/DI 92 33
1369-11 of this chapter.
1370-(b) It is a defense to a prosecution for an offense described in
1371-subsection (a) that all of the following apply:
1372-(1) The controlled substance is hemp (as defined in 7 U.S.C.
1373-1639o(1)). (2) The controlled substance was being shipped
1374-from a licensed producer in another state in continuous
1375-transit through Indiana to a licensed handler in another
1376-state.".
1377-Renumber all SECTIONS consecutively.
1378-(Reference is to SB 209 as reprinted January 25, 2022.)
1379-YOUNG M
1380-_____
1381-COMMITTEE REPORT
1382-Mr. Speaker: Your Committee on Courts and Criminal Code, to
1383-which was referred Senate Bill 209, has had the same under
1384-consideration and begs leave to report the same back to the House with
1385-the recommendation that said bill be amended as follows:
1386-Page 1, delete lines 1 through 17.
1387-Page 2, delete lines 1 through 41.
1388-Page 12, delete lines 23 through 36.
1389-Page 17, line 14, delete "designation:" and insert "designation:".
1390-Page 21, delete lines 10 through 26, begin a new paragraph and
1391-insert:
1392-"SECTION 4. [EFFECTIVE UPON PASSAGE] (a) The legislative
1393-council is urged to assign to the interim study committee on
1394-corrections and criminal code, during the 2022 legislative interim,
1395-the task of studying "delta-8 THC" and any of its related
1396-psychoactive cannabinoids.
1397- (b) This SECTION expires January 1, 2023.
1398-SECTION 5. An emergency is declared for this act.".
1399-Renumber all SECTIONS consecutively.
1400-and when so amended that said bill do pass.
1401-(Reference is to SB 209 as reprinted January 28, 2022.)
1402-MCNAMARA
1403-Committee Vote: yeas 9, nays 0.
1404-ES 209—LS 6921/DI 92
1404+SB 209—LS 6921/DI 92